Inmaculada Navas

535 total citations
5 papers, 159 citations indexed

About

Inmaculada Navas is a scholar working on Neurology, Clinical Psychology and Epidemiology. According to data from OpenAlex, Inmaculada Navas has authored 5 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 2 papers in Clinical Psychology and 2 papers in Epidemiology. Recurrent topics in Inmaculada Navas's work include Neurological disorders and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Transcranial Magnetic Stimulation Studies (1 paper). Inmaculada Navas is often cited by papers focused on Neurological disorders and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Transcranial Magnetic Stimulation Studies (1 paper). Inmaculada Navas collaborates with scholars based in Spain. Inmaculada Navas's co-authors include Salvador Quintana, Esther Cubo, Ana I. Rojo, Maite Garolera, M. Aguilar, Esteban Peña, Ignacio J. Posada, Cristina Prieto, Lydia López Manzanares and Mónica Kurtis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Parkinsonism & Related Disorders and Frontiers in Neurology.

In The Last Decade

Inmaculada Navas

5 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inmaculada Navas Spain	5	123	33	29	24	21	5	159
Onanong Phokaewvarangkul Thailand	10	181 1.5×	18 0.5×	32 1.1×	39 1.6×	16 0.8×	36	228
Márk Harmat Hungary	7	207 1.7×	26 0.8×	36 1.2×	32 1.3×	47 2.2×	9	248
Massimo Pederzoli Italy	5	162 1.3×	37 1.1×	33 1.1×	40 1.7×	26 1.2×	7	202
Eva‐Juliane Vollstedt Germany	7	104 0.8×	13 0.4×	26 0.9×	17 0.7×	34 1.6×	10	157
B. Robottom United States	10	206 1.7×	38 1.2×	28 1.0×	73 3.0×	61 2.9×	26	288
Robbert W. K. Borgemeester Netherlands	7	201 1.6×	14 0.4×	39 1.3×	31 1.3×	19 0.9×	10	231
W.M. Michael Schuepbach Switzerland	6	82 0.7×	18 0.5×	37 1.3×	18 0.8×	14 0.7×	9	144
Marco Fernandes Portugal	7	118 1.0×	37 1.1×	38 1.3×	33 1.4×	17 0.8×	21	163
Mari Muldmaa Estonia	5	121 1.0×	26 0.8×	23 0.8×	16 0.7×	22 1.0×	8	170
Purba Basu India	6	102 0.8×	28 0.8×	14 0.5×	32 1.3×	10 0.5×	23	181

Countries citing papers authored by Inmaculada Navas

Since Specialization

Citations

This map shows the geographic impact of Inmaculada Navas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Navas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Navas more than expected).

Fields of papers citing papers by Inmaculada Navas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Navas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Navas. The network helps show where Inmaculada Navas may publish in the future.

Co-authorship network of co-authors of Inmaculada Navas

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Navas. A scholar is included among the top collaborators of Inmaculada Navas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Navas. Inmaculada Navas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Navas, Inmaculada, et al.. (2021). Protocol for a randomized pilot study (FIRST STEPS): implementation of the Incredible Years-ASLD® program in Spanish children with autism and preterm children with communication and/or socialization difficulties. Trials. 22(1). 291–291. 5 indexed citations

2.

Rigual, Ricardo, María Alonso de Leciñana, Jaime Masjuán, et al.. (2020). Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry. Frontiers in Neurology. 11. 575634–575634. 5 indexed citations

3.

Peña, Esteban, Lydia López Manzanares, Mónica Kurtis, et al.. (2018). Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid. SHILAP Revista de lepidopterología. 33(6). 395–402. 7 indexed citations

4.

Peña, Esteban, Lydia López Manzanares, Mónica Kurtis, et al.. (2016). Antidepresivos en la enfermedad de Parkinson. Recomendaciones del grupo de trastornos del movimiento de la Asociación Madrileña de Neurología. Neurología. 33(6). 395–402. 16 indexed citations

5.

Rojo, Ana I., M. Aguilar, Maite Garolera, et al.. (2003). Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism & Related Disorders. 10(1). 23–28. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact